drugset / Trial / NCT03076905

Pharmacokinetics of IV Formulation

NCT03076905

NaSingle-groupOpen-labelTreatment

Summary

Open label evaluation of a single intravenous dose of F901318 to healthy male and female subjects with pharmacokinetic and safety and tolerability evaluation.

Timeline

Start
2017-05
Primary completion
2017-07
Completion
2017-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Olorofim Small molecule 4 mg/kg Intravenous